Close Menu

NEW YORK – UK molecular diagnostics firm MicrosensDx said on Thursday that its RapiPro LAMP SARS-CoV-2 test has garnered CE marking. 

The loop-mediated isothermal amplification test returns results in less than 30 minutes and has shown 97 percent sensitivity and 96 percent specificity in validation studies, the company said in a statement. The sensitivity and specificity numbers are for both symptomatic and asymptomatic individuals and include people with low and high viral loads.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.